Getting Pregnant on Tirzepatide: What the Guidance Actually Says

Why tirzepatide is not recommended before or during pregnancy

The starting point is the evidence base, or more accurately, the gap in it. Tirzepatide's prescribing information, published on the electronic Medicines Compendium, confirms that there are no adequate data from use of tirzepatide in pregnant women. Animal studies have shown adverse effects on the developing foetus at exposures relevant to human doses. That combination (no reassuring human data, plus concerning animal findings) is why the precautionary position is firm. The MHRA's guidance on GLP-1 medicines, published on GOV.UK, is explicit: these medicines should not be used during pregnancy.

This is not unique to tirzepatide. The same not-recommended status applies across the GLP-1 class. The NHS England guidance on weight-management injections reinforces the message: if you are planning a pregnancy, speak to your healthcare team about stopping treatment in advance. Stopping promptly matters because tirzepatide has a half-life that means the medicine remains active in the body for some time after the final injection. How long to wait before trying to conceive is a question for your prescriber or GP, who will factor in your individual clinical picture.

The situation described above (known guidance, limited human data, a clear precautionary recommendation) is straightforward. What is less clear is exactly what a very early unintended exposure means for an individual pregnancy. That uncertainty is precisely why a conversation with a healthcare professional, rather than online reassurance, is the right next step. If you are wondering whether you can get pregnant on tirzepatide, including what the evidence says about fertility and conception while on treatment, that page brings together what is currently understood. You can read more about the broader considerations around getting pregnant on Mounjaro on a dedicated page.

Contraception while taking tirzepatide: the pill absorption issue

One of the most practically important facts for women of reproductive age on tirzepatide concerns the oral contraceptive pill. Tirzepatide slows gastric emptying, the rate at which the stomach passes its contents to the small intestine. That delay can reduce the absorption of medicines taken by mouth, including the combined and progestogen-only pill.

NHS guidance, corroborated by the NHS Inform Scotland resource on diabetes and weight-loss medication, advises that women on oral contraceptives should use an additional non-oral method of contraception (such as condoms) for the first four weeks of starting tirzepatide and for four weeks after every dose increase. This is not an academic footnote. A woman moving from 2.5mg to 5mg, or from 5mg to 7.5mg, restarts that four-week window each time. Missing it creates a real risk of unintended pregnancy.

No equivalent evidence exists for semaglutide reducing pill effectiveness, which is a notable distinction between the two medicines. NHS England's guidance on weight-management injections also raises the point about transdermal HRT (patches or gels) as the preferred form of HRT while on tirzepatide, for the same absorption reason. If you use any hormonally-based treatment, it is worth raising this with whoever prescribes it. A related question that often comes up alongside contraception queries is whether you can drink on Mounjaro, and that page covers the alcohol and tirzepatide interaction in practical detail. Our frequently asked questions page covers a number of related practicalities.

If you discover you are pregnant while taking tirzepatide

Finding out you are pregnant while on tirzepatide is understandably unsettling. The immediate practical steps are simple: stop taking the medicine and contact your GP or midwife as soon as possible. Do not wait until your next scheduled prescription review or clinical check-in.

Your GP will likely refer you to midwifery care in the usual way and will be aware that you were taking a weight-management medicine. They do not need a full clinical handover from your prescribing pharmacy before they can support you, any private prescriber, including ours, can be informed of the pregnancy so that your records are updated and no further treatment is dispatched. If you are a nume patient and you become pregnant, contact us directly and we will pause your treatment and inform your GP in line with our standard notification process.

The question patients most often ask at this point is whether early exposure to tirzepatide causes harm. Honestly, the answer is that we do not know with certainty, the data simply do not exist yet. That uncertainty is why stopping promptly is the right approach, and why ongoing care is provided by your obstetric team rather than a weight-management service. For a fuller picture of what is understood about unintended pregnancy while on tirzepatide, that page sets out what is currently known and what remains uncertain.

Planning ahead: stopping tirzepatide before trying to conceive

For women who are planning to become pregnant rather than responding to an unintended one, the guidance allows for a more considered transition. The key steps are: discuss your plans with your GP or prescriber well in advance, agree a timeline for stopping tirzepatide, understand the wash-out period recommended before trying to conceive, and think about what (if anything) you would like to have in place for weight management during pregnancy and postnatally. Our page on women getting pregnant on Mounjaro covers how others have approached this planning process and what questions tend to come up.

Weight management during pregnancy is handled by your maternity team and does not involve GLP-1 medicines. Many women find that the progress made while on tirzepatide can be maintained with the lifestyle habits built during treatment, though this varies considerably from person to person. Some women may want to revisit treatment after the postpartum period, and if you have concerns about what to do if you find yourself pregnant on tirzepatide, that page explains the practical steps and what to expect from your care team. If you are considering pausing treatment temporarily while exploring your options, speak to our prescribers, that kind of clinical conversation is exactly what the consultation is for. There is no pressure to make a fast decision, and a good prescriber will not expect one. Take the time the situation deserves.